Literature DB >> 35261684

Unilateral Tonsillar Swelling as a Manifestation of Diffuse Large B Cell Lymphoma (DLBCL): Case Report.

Wulyo Rajabato1, Vitya Chandika1, Agnes Stephanie Harahap2.   

Abstract

Approximately 30-40% of all diffuse large B-cell lymphoma (DLBCL) cases, which have initially been present in extranodal sites with the most common involvement, were found at the level of the gastrointestinal tract (34%), head and neck (13.6%), and skin/soft tissue (10.6%). More than half of head and neck lymphomas occur in the Waldeyer ring, with 40% to 50% of these arising from the tonsil. The majority of tonsil lymphomas are B-cell origin, and DLBCL is the most common histological type. Here we presented a case of tonsillar DLBCL with long-term complete remission after R-CHOP treatment.

Entities:  

Year:  2021        PMID: 35261684      PMCID: PMC8897779          DOI: 10.26574/maedica.2020.16.4.750

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  7 in total

Review 1.  Malignant lymphoma of the head and neck.

Authors:  E Zapater; J V Bagán; F Carbonell; J Basterra
Journal:  Oral Dis       Date:  2010-03       Impact factor: 3.511

2.  Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  H Tilly; M Gomes da Silva; U Vitolo; A Jack; M Meignan; A Lopez-Guillermo; J Walewski; M André; P W Johnson; M Pfreundschuh; M Ladetto
Journal:  Ann Oncol       Date:  2015-09       Impact factor: 32.976

3.  Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.

Authors:  Jorge J Castillo; Eric S Winer; Adam J Olszewski
Journal:  Am J Hematol       Date:  2014-02-19       Impact factor: 10.047

Review 4.  Primary extranodal B-cell lymphoma: current concepts and treatment strategies.

Authors:  Barbara Vannata; Emanuele Zucca
Journal:  Chin Clin Oncol       Date:  2015-03

5.  Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  U Vitolo; J F Seymour; M Martelli; G Illerhaus; T Illidge; E Zucca; E Campo; M Ladetto
Journal:  Ann Oncol       Date:  2016-07-04       Impact factor: 32.976

6.  Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?

Authors:  Siddhartha Laskar; Gaurav Bahl; Mary Ann Muckaden; Reena Nair; Sudeep Gupta; Ashish Bakshi; Sumeet Gujral; Tanuja Shet; Shyam Kishore Shrivastava; Ketayun Ardeshir Dinshaw
Journal:  Cancer       Date:  2007-08-15       Impact factor: 6.860

Review 7.  Treatment of diffuse large B cell lymphoma.

Authors:  Jae-Yong Kwak
Journal:  Korean J Intern Med       Date:  2012-11-27       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.